Share Price and Basic Stock Data
Last Updated: December 8, 2025, 2:06 pm
| PEG Ratio | -28.46 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Expleo Solutions Ltd operates in the IT consulting and software industry, where it has carved a niche for itself. The company’s revenue trajectory has been impressive, with sales climbing from ₹743 Cr in FY 2022 to ₹903 Cr in FY 2023, and further reaching ₹965 Cr in FY 2024. The trailing twelve months (TTM) revenue currently stands at ₹1,032 Cr, indicating a consistent upward trend. This growth can be attributed to a robust demand for digital transformation services, which has been a focal point for many organizations post-pandemic. The company’s quarterly sales figures also reflect solid performance, with the most recent quarter reporting ₹255 Cr. However, the somewhat stagnant growth in the last two quarters raises questions about maintaining momentum amid a competitive landscape.
Profitability and Efficiency Metrics
Profitability metrics for Expleo Solutions present a mixed picture. The operating profit margin (OPM) has fluctuated, with a notable peak of 30% in December 2022, but has since declined to about 11% in June 2025. This decline could hint at rising operational costs or pricing pressures. The net profit has shown resilience, recording ₹134 Cr in FY 2023 and expected to reach ₹103 Cr in FY 2025, translating to an EPS of ₹66.52. Moreover, the return on equity (ROE) stands at a commendable 16.3%, while return on capital employed (ROCE) is at 21.5%. These figures suggest that Expleo is effectively utilizing its equity and capital to generate profits, but the volatility in margins necessitates closer scrutiny as it could impact future profitability.
Balance Sheet Strength and Financial Ratios
Expleo’s balance sheet appears solid, with total assets reported at ₹831 Cr against total liabilities of ₹916 Cr. The company has maintained a low borrowing level, with borrowings at just ₹20 Cr, which translates to a comfortable interest coverage ratio of 54.75x. This indicates that Expleo can easily meet its interest obligations, showcasing financial stability. Additionally, the company holds reserves of ₹688 Cr, providing a cushion for future investments or market fluctuations. However, the current ratio of 3.90 suggests that while liquidity is high, the company must ensure that it efficiently manages its working capital to avoid tying up excessive resources in non-productive assets.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Expleo Solutions reveals a strong promoter backing, with promoters holding 71.05% of the equity. This significant stake indicates confidence from the management. However, foreign institutional investors (FIIs) have a negligible stake of 0.13%, which could suggest limited interest from international markets. Domestic institutional investors (DIIs) hold a mere 0.84%, further highlighting the stock’s appeal primarily among retail investors. The number of shareholders has increased to 29,017, reflecting growing retail interest. This could be a positive sign of increased investor confidence, but the low institutional participation may raise concerns about the stock’s stability during market volatility.
Outlook, Risks, and Final Insight
Looking ahead, Expleo Solutions faces a blend of opportunities and risks. The continued demand for IT consulting services bodes well for revenue growth, but the fluctuating profit margins may pose challenges. The company’s ability to manage operational costs effectively will be crucial. Additionally, with a significant portion of ownership resting with promoters, market sentiment can be heavily influenced by their strategic decisions. Risks include potential economic downturns that could lead to reduced IT spending by clients, and competition from larger players in the IT sector. Investors should consider these factors carefully, weighing the company’s solid fundamentals against the inherent risks in the sector. Overall, while Expleo Solutions has a robust operational framework, the management’s ability to navigate market pressures will be key to sustaining growth and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Expleo Solutions Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 45.5 Cr. | 14.4 | 14.4/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 151 Cr. | 140 | 194/99.8 | 23.0 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 26.4 Cr. | 206 | 310/140 | 18.8 | 26.7 | 0.49 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 4.75 Cr. | 0.97 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,546.40 Cr | 553.28 | 87.54 | 123.78 | 0.55% | 14.89% | 20.93% | 6.84 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 212 | 220 | 240 | 231 | 225 | 234 | 250 | 255 | 252 | 259 | 258 | 256 | 260 |
| Expenses | 176 | 178 | 168 | 188 | 192 | 200 | 212 | 221 | 213 | 217 | 219 | 216 | 230 |
| Operating Profit | 37 | 42 | 72 | 43 | 33 | 34 | 38 | 34 | 39 | 42 | 39 | 40 | 30 |
| OPM % | 17% | 19% | 30% | 19% | 15% | 14% | 15% | 13% | 15% | 16% | 15% | 16% | 11% |
| Other Income | 1 | 1 | 13 | 4 | 2 | 2 | 11 | 2 | 2 | 13 | 3 | 5 | 7 |
| Interest | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 9 | 9 | 10 | 12 | 8 | 8 |
| Profit before tax | 31 | 36 | 77 | 39 | 26 | 27 | 41 | 26 | 31 | 44 | 28 | 36 | 28 |
| Tax % | 25% | 33% | 28% | 26% | 22% | 24% | 16% | 40% | 23% | 20% | 30% | 32% | 28% |
| Net Profit | 23 | 24 | 55 | 29 | 20 | 21 | 34 | 16 | 24 | 35 | 20 | 24 | 20 |
| EPS in Rs | 22.39 | 23.38 | 54.00 | 28.34 | 13.01 | 13.22 | 21.93 | 10.12 | 15.40 | 22.87 | 12.75 | 15.52 | 13.16 |
Last Updated: August 20, 2025, 11:00 am
Below is a detailed analysis of the quarterly data for Expleo Solutions Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 260.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Mar 2025) to 260.00 Cr., marking an increase of 4.00 Cr..
- For Expenses, as of Jun 2025, the value is 230.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 216.00 Cr. (Mar 2025) to 230.00 Cr., marking an increase of 14.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Mar 2025) to 30.00 Cr., marking a decrease of 10.00 Cr..
- For OPM %, as of Jun 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 11.00%, marking a decrease of 5.00%.
- For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2025) to 28.00 Cr., marking a decrease of 8.00 Cr..
- For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be improving (decreasing) as expected. It has decreased from 32.00% (Mar 2025) to 28.00%, marking a decrease of 4.00%.
- For Net Profit, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 4.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 13.16. The value appears to be declining and may need further review. It has decreased from 15.52 (Mar 2025) to 13.16, marking a decrease of 2.36.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:22 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 194 | 214 | 264 | 260 | 271 | 283 | 270 | 301 | 743 | 903 | 965 | 1,025 | 1,032 |
| Expenses | 155 | 177 | 210 | 219 | 231 | 230 | 217 | 231 | 618 | 703 | 816 | 859 | 882 |
| Operating Profit | 40 | 37 | 54 | 41 | 40 | 53 | 53 | 70 | 124 | 200 | 149 | 166 | 151 |
| OPM % | 20% | 17% | 20% | 16% | 15% | 19% | 20% | 23% | 17% | 22% | 15% | 16% | 15% |
| Other Income | 10 | 2 | 6 | 1 | 13 | 6 | 8 | 5 | 6 | 16 | 7 | 16 | 27 |
| Interest | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 3 | 3 | 3 |
| Depreciation | 6 | 5 | 4 | 5 | 6 | 6 | 6 | 6 | 19 | 28 | 34 | 39 | 38 |
| Profit before tax | 42 | 32 | 56 | 37 | 48 | 54 | 54 | 68 | 110 | 186 | 120 | 139 | 137 |
| Tax % | 29% | 32% | 34% | 36% | 33% | 32% | 26% | 26% | 39% | 28% | 24% | 26% | |
| Net Profit | 30 | 22 | 37 | 24 | 32 | 36 | 40 | 50 | 68 | 134 | 90 | 103 | 100 |
| EPS in Rs | 29.26 | 20.53 | 34.68 | 22.29 | 29.86 | 33.79 | 38.92 | 49.20 | 66.01 | 130.59 | 58.27 | 66.52 | 64.30 |
| Dividend Payout % | 31% | 117% | 69% | 108% | 80% | 0% | 0% | 0% | 0% | 6% | 0% | 75% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.67% | 68.18% | -35.14% | 33.33% | 12.50% | 11.11% | 25.00% | 36.00% | 97.06% | -32.84% | 14.44% |
| Change in YoY Net Profit Growth (%) | 0.00% | 94.85% | -103.32% | 68.47% | -20.83% | -1.39% | 13.89% | 11.00% | 61.06% | -129.89% | 47.28% |
Expleo Solutions Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 31% |
| 3 Years: | 11% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 21% |
| 3 Years: | 14% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 16% |
| 3 Years: | -8% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 21% |
| 3 Years: | 20% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 3:50 am
Balance Sheet
Last Updated: December 4, 2025, 1:13 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 11 | 11 | 11 | 11 | 11 | 10 | 10 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 98 | 91 | 98 | 116 | 118 | 128 | 142 | 192 | 379 | 515 | 596 | 620 | 688 |
| Borrowings | 12 | 10 | 0 | 0 | 0 | 0 | 0 | 7 | 15 | 26 | 26 | 30 | 20 |
| Other Liabilities | 27 | 54 | 73 | 43 | 63 | 53 | 62 | 56 | 185 | 174 | 128 | 165 | 192 |
| Total Liabilities | 147 | 165 | 182 | 171 | 191 | 192 | 214 | 264 | 594 | 730 | 765 | 831 | 916 |
| Fixed Assets | 27 | 24 | 25 | 27 | 22 | 19 | 26 | 25 | 108 | 142 | 131 | 113 | 91 |
| CWIP | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | 5 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 |
| Other Assets | 119 | 139 | 157 | 144 | 169 | 173 | 188 | 239 | 480 | 582 | 614 | 719 | 825 |
| Total Assets | 147 | 165 | 182 | 171 | 191 | 192 | 214 | 264 | 594 | 730 | 765 | 831 | 916 |
Below is a detailed analysis of the balance sheet data for Expleo Solutions Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
- For Reserves, as of Sep 2025, the value is 688.00 Cr.. The value appears strong and on an upward trend. It has increased from 620.00 Cr. (Mar 2025) to 688.00 Cr., marking an increase of 68.00 Cr..
- For Borrowings, as of Sep 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 30.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 10.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 192.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 165.00 Cr. (Mar 2025) to 192.00 Cr., marking an increase of 27.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 916.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 831.00 Cr. (Mar 2025) to 916.00 Cr., marking an increase of 85.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 91.00 Cr.. The value appears to be declining and may need further review. It has decreased from 113.00 Cr. (Mar 2025) to 91.00 Cr., marking a decrease of 22.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 825.00 Cr.. The value appears strong and on an upward trend. It has increased from 719.00 Cr. (Mar 2025) to 825.00 Cr., marking an increase of 106.00 Cr..
- For Total Assets, as of Sep 2025, the value is 916.00 Cr.. The value appears strong and on an upward trend. It has increased from 831.00 Cr. (Mar 2025) to 916.00 Cr., marking an increase of 85.00 Cr..
Notably, the Reserves (688.00 Cr.) exceed the Borrowings (20.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 28.00 | 27.00 | 54.00 | 41.00 | 40.00 | 53.00 | 53.00 | 63.00 | 109.00 | 174.00 | 123.00 | 136.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 105 | 97 | 75 | 60 | 92 | 59 | 103 | 74 | 85 | 97 | 94 | 79 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 105 | 97 | 75 | 60 | 92 | 59 | 103 | 74 | 85 | 97 | 94 | 79 |
| Working Capital Days | 68 | 23 | -7 | 8 | 21 | 15 | 50 | 48 | 46 | 93 | 112 | 67 |
| ROCE % | 40% | 29% | 51% | 31% | 38% | 40% | 38% | 39% | 36% | 39% | 20% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Invesco India Multicap Fund | 133,972 | 0.66 | 17.73 | 133,972 | 2025-04-22 15:56:58 | 0% |
| Invesco India Smallcap Fund | 127,985 | 0.59 | 16.93 | 127,985 | 2025-04-22 15:56:58 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 66.52 | 58.27 | 86.27 | 52.58 | 49.20 |
| Diluted EPS (Rs.) | 66.52 | 58.27 | 86.27 | 52.58 | 49.20 |
| Cash EPS (Rs.) | 91.85 | 79.96 | 157.79 | 60.32 | 54.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 409.69 | 393.78 | 512.06 | 248.93 | 196.90 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 409.69 | 393.78 | 512.06 | 248.93 | 196.90 |
| Revenue From Operations / Share (Rs.) | 660.31 | 621.69 | 881.09 | 394.57 | 293.50 |
| PBDIT / Share (Rs.) | 117.18 | 100.42 | 210.93 | 78.85 | 73.42 |
| PBIT / Share (Rs.) | 91.86 | 78.73 | 183.73 | 71.11 | 67.75 |
| PBT / Share (Rs.) | 89.72 | 77.05 | 181.53 | 70.37 | 66.72 |
| Net Profit / Share (Rs.) | 66.52 | 58.27 | 130.60 | 52.58 | 49.20 |
| NP After MI And SOA / Share (Rs.) | 66.52 | 58.27 | 130.60 | 52.58 | 49.20 |
| PBDIT Margin (%) | 17.74 | 16.15 | 23.93 | 19.98 | 25.01 |
| PBIT Margin (%) | 13.91 | 12.66 | 20.85 | 18.02 | 23.08 |
| PBT Margin (%) | 13.58 | 12.39 | 20.60 | 17.83 | 22.73 |
| Net Profit Margin (%) | 10.07 | 9.37 | 14.82 | 13.32 | 16.76 |
| NP After MI And SOA Margin (%) | 10.07 | 9.37 | 14.82 | 13.32 | 16.76 |
| Return on Networth / Equity (%) | 16.23 | 14.79 | 25.50 | 21.12 | 24.98 |
| Return on Capital Employeed (%) | 20.76 | 18.48 | 33.48 | 27.11 | 33.16 |
| Return On Assets (%) | 12.42 | 11.82 | 18.33 | 15.65 | 19.08 |
| Asset Turnover Ratio (%) | 1.28 | 1.29 | 1.84 | 1.46 | 1.36 |
| Current Ratio (X) | 3.90 | 5.77 | 3.30 | 3.84 | 4.11 |
| Quick Ratio (X) | 3.90 | 5.77 | 3.30 | 3.84 | 4.11 |
| Dividend Payout Ratio (NP) (%) | 75.16 | 8.58 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 54.43 | 6.25 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 24.84 | 91.42 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 45.57 | 93.75 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 54.75 | 59.74 | 95.85 | 106.51 | 71.28 |
| Interest Coverage Ratio (Post Tax) (X) | 32.08 | 35.66 | 60.35 | 72.02 | 48.77 |
| Enterprise Value (Cr.) | 1006.97 | 1697.97 | 1111.70 | 1571.40 | 398.52 |
| EV / Net Operating Revenue (X) | 0.98 | 1.76 | 1.23 | 3.88 | 1.32 |
| EV / EBITDA (X) | 5.54 | 10.89 | 5.14 | 19.44 | 5.29 |
| MarketCap / Net Operating Revenue (X) | 1.21 | 1.95 | 1.40 | 4.27 | 1.76 |
| Retention Ratios (%) | 24.83 | 91.41 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.94 | 3.08 | 2.41 | 6.77 | 2.62 |
| Price / Net Operating Revenue (X) | 1.21 | 1.95 | 1.40 | 4.27 | 1.76 |
| EarningsYield | 0.08 | 0.04 | 0.10 | 0.03 | 0.09 |
After reviewing the key financial ratios for Expleo Solutions Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For Diluted EPS (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For Cash EPS (Rs.), as of Mar 25, the value is 91.85. This value is within the healthy range. It has increased from 79.96 (Mar 24) to 91.85, marking an increase of 11.89.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 409.69. It has increased from 393.78 (Mar 24) to 409.69, marking an increase of 15.91.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 409.69. It has increased from 393.78 (Mar 24) to 409.69, marking an increase of 15.91.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 660.31. It has increased from 621.69 (Mar 24) to 660.31, marking an increase of 38.62.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 117.18. This value is within the healthy range. It has increased from 100.42 (Mar 24) to 117.18, marking an increase of 16.76.
- For PBIT / Share (Rs.), as of Mar 25, the value is 91.86. This value is within the healthy range. It has increased from 78.73 (Mar 24) to 91.86, marking an increase of 13.13.
- For PBT / Share (Rs.), as of Mar 25, the value is 89.72. This value is within the healthy range. It has increased from 77.05 (Mar 24) to 89.72, marking an increase of 12.67.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For PBDIT Margin (%), as of Mar 25, the value is 17.74. This value is within the healthy range. It has increased from 16.15 (Mar 24) to 17.74, marking an increase of 1.59.
- For PBIT Margin (%), as of Mar 25, the value is 13.91. This value is within the healthy range. It has increased from 12.66 (Mar 24) to 13.91, marking an increase of 1.25.
- For PBT Margin (%), as of Mar 25, the value is 13.58. This value is within the healthy range. It has increased from 12.39 (Mar 24) to 13.58, marking an increase of 1.19.
- For Net Profit Margin (%), as of Mar 25, the value is 10.07. This value exceeds the healthy maximum of 10. It has increased from 9.37 (Mar 24) to 10.07, marking an increase of 0.70.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.07. This value is within the healthy range. It has increased from 9.37 (Mar 24) to 10.07, marking an increase of 0.70.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.23. This value is within the healthy range. It has increased from 14.79 (Mar 24) to 16.23, marking an increase of 1.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.76. This value is within the healthy range. It has increased from 18.48 (Mar 24) to 20.76, marking an increase of 2.28.
- For Return On Assets (%), as of Mar 25, the value is 12.42. This value is within the healthy range. It has increased from 11.82 (Mar 24) to 12.42, marking an increase of 0.60.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.28. It has decreased from 1.29 (Mar 24) to 1.28, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 3. It has decreased from 5.77 (Mar 24) to 3.90, marking a decrease of 1.87.
- For Quick Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 2. It has decreased from 5.77 (Mar 24) to 3.90, marking a decrease of 1.87.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 75.16. This value exceeds the healthy maximum of 50. It has increased from 8.58 (Mar 24) to 75.16, marking an increase of 66.58.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 54.43. This value exceeds the healthy maximum of 50. It has increased from 6.25 (Mar 24) to 54.43, marking an increase of 48.18.
- For Earning Retention Ratio (%), as of Mar 25, the value is 24.84. This value is below the healthy minimum of 40. It has decreased from 91.42 (Mar 24) to 24.84, marking a decrease of 66.58.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 45.57. This value is within the healthy range. It has decreased from 93.75 (Mar 24) to 45.57, marking a decrease of 48.18.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 54.75. This value is within the healthy range. It has decreased from 59.74 (Mar 24) to 54.75, marking a decrease of 4.99.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 32.08. This value is within the healthy range. It has decreased from 35.66 (Mar 24) to 32.08, marking a decrease of 3.58.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,006.97. It has decreased from 1,697.97 (Mar 24) to 1,006.97, marking a decrease of 691.00.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.76 (Mar 24) to 0.98, marking a decrease of 0.78.
- For EV / EBITDA (X), as of Mar 25, the value is 5.54. This value is within the healthy range. It has decreased from 10.89 (Mar 24) to 5.54, marking a decrease of 5.35.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.21, marking a decrease of 0.74.
- For Retention Ratios (%), as of Mar 25, the value is 24.83. This value is below the healthy minimum of 30. It has decreased from 91.41 (Mar 24) to 24.83, marking a decrease of 66.58.
- For Price / BV (X), as of Mar 25, the value is 1.94. This value is within the healthy range. It has decreased from 3.08 (Mar 24) to 1.94, marking a decrease of 1.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.21, marking a decrease of 0.74.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Expleo Solutions Ltd:
- Net Profit Margin: 10.07%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.76% (Industry Average ROCE: 14.89%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.23% (Industry Average ROE: 20.93%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 32.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.9
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.9 (Industry average Stock P/E: 87.54)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.07%
About the Company - Expleo Solutions Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 6A, Sixth Floor, Prince Infocity II, Chennai (Madras) Tamil Nadu 600096 | investor.expleosol@expleogroup.com https://investors.expleo.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ralph Franz Gillessen | Chairman & Non-Exe.Director |
| Prof. K Kumar | Deputy Chairman |
| Mr. Balaji Viswanathan | Managing Director & CEO |
| Mr. Prashant Eknath Bramhankar | Whole Time Director & COO |
| Mr. Rajesh Krishnamurthy | Non Executive Director |
| Ms. Lilian Jessie Paul | Independent Director |
| Prof. S Rajagopalan | Independent Director |
| Mr. Rajiv Kuchhal | Independent Director |
| Mr. Ulrich Baumer | Independent Director |
Expleo Solutions Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹1,321.90 |
| Previous Day | ₹1,321.90 |
FAQ
What is the intrinsic value of Expleo Solutions Ltd?
Expleo Solutions Ltd's intrinsic value (as of 08 December 2025) is 924.34 which is 7.29% lower the current market price of 997.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,548 Cr. market cap, FY2025-2026 high/low of 1,567/686, reserves of ₹688 Cr, and liabilities of 916 Cr.
What is the Market Cap of Expleo Solutions Ltd?
The Market Cap of Expleo Solutions Ltd is 1,548 Cr..
What is the current Stock Price of Expleo Solutions Ltd as on 08 December 2025?
The current stock price of Expleo Solutions Ltd as on 08 December 2025 is 997.
What is the High / Low of Expleo Solutions Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Expleo Solutions Ltd stocks is 1,567/686.
What is the Stock P/E of Expleo Solutions Ltd?
The Stock P/E of Expleo Solutions Ltd is 14.9.
What is the Book Value of Expleo Solutions Ltd?
The Book Value of Expleo Solutions Ltd is 453.
What is the Dividend Yield of Expleo Solutions Ltd?
The Dividend Yield of Expleo Solutions Ltd is 5.02 %.
What is the ROCE of Expleo Solutions Ltd?
The ROCE of Expleo Solutions Ltd is 21.5 %.
What is the ROE of Expleo Solutions Ltd?
The ROE of Expleo Solutions Ltd is 16.3 %.
What is the Face Value of Expleo Solutions Ltd?
The Face Value of Expleo Solutions Ltd is 10.0.